Vitamin D helps PCOS most and IVF least across 5 reproductive conditions - review

Endocrine roles of vitamin D in female reproduction: Mechanisms and clinical implications

Women's Health (SAGE), Volume 22:1–34, 2026, https://doi.org/10.1177/17455057261446942

Azza Alsuwaidi, Fatme AlAnouti, Dimitrios Papandreou

Summary by Claude - June 2026

Correcting vitamin D deficiency reliably improves metabolic and hormonal markers in women's reproductive conditions — but it rarely translates into proven gains in the outcomes that matter most (live birth, preeclampsia prevention) unless the deficiency is real and treated early. This is a narrative review (SANRA-guided, not a meta-analysis — no pooled effect sizes, no risk-of-bias scoring) covering roughly 80 studies published 2013–2025 across PMS, PCOS, uterine pathologies, pregnancy, and IVF in reproductive-age women.

By condition: PCOS has the strongest support — multiple RCTs (often 50,000 IU weekly) lower insulin resistance, total testosterone, and free-androgen index, raise SHBG, and regularize cycles, especially in obese/insulin-resistant women — yet reproductive endpoints stay inconsistent, and the largest live-birth trial found no benefit. Pregnancy shows strong observational links to preeclampsia, gestational diabetes, and preterm birth, but conflicting trials; the standout positive trial gave 60,000 IU monthly from the first trimester and cut preeclampsia (RR 0.36), preterm delivery (RR 0.50), and low birthweight (RR 0.43). Endometriosis/fibroids show pain and inflammatory-marker improvements in small trials; one fibroid RCT halted growth but between-group shrinkage missed significance (P=0.085). IVF is weakest — early dosing across folliculogenesis may help, but single pre-transfer boluses don't (SUNDRO: 600,000 IU once, no benefit).

A key mechanistic thread: pregnancy raises VDBP 40–50%, inflating total 25(OH)D while free vitamin D stays low, so "sufficient" totals can mask functional deficiency.

What this does not show: as a narrative review it pools nothing and scores no bias; conclusions rest on heterogeneous, mostly small single-center trials. It can't prove causation, define optimal dose/timing, or set guidelines. Most trials measured total — not free/bioavailable — 25(OH)D, and many enrolled already-replete women, biasing reproductive outcomes toward null.

PDF


Related in Vitamin D Life

PCOS

Pregnancy

Endometriosis

Fertility/IVF

VDBP/free-vitamin-D

PMS